Live feed
·
INSIDERFilingvia Quantisnow
Cerevel Therapeutics Holdings Inc. logo

Bodenrader Mark converted options into 19,284 shares and sold $326,788 worth of shares (7,889 units at $41.42), increasing direct ownership by 180% to 17,724 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Cerevel Therapeutics Holdings Inc. logo
CERE
Cerevel Therapeutics Holdings Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2020
Get push alerts for CERE

Follow CERE and get a push notification the moment its next story breaks.

Full CERE profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERE (Cerevel Therapeutics Holdings Inc.) and more on Quantisnow.